The RolE of Prolonged Nightly faSTing to Improve Sleep and cOgnition in bREast Cancer Survivors
RESTORE
1 other identifier
interventional
60
1 country
1
Brief Summary
The investigators are interested in finding out how Prolonged Nightly Fasting (PNF) and/or health education may impact health and cancer recovery for breast cancer patients and survivors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 18, 2025
CompletedFirst Submitted
Initial submission to the registry
March 28, 2025
CompletedFirst Posted
Study publicly available on registry
April 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
May 1, 2026
April 1, 2026
1.8 years
March 28, 2025
April 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Examine PNF-induced changes in cognitive function as compared to the HED-Only control condition.
The Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) will be used to assess subjective cognitive function using a scale of 0-156
Baseline (T1) and 8-week end point (T2) data collection
Examine PNF-induced changes in cognitive function as compared to the HED-Only control condition.
The Montreal Cognitive Assessment (T-MoCA) will be used to assess objective cognitive assessment using a scale of 0-22
Baseline (T1) and 8-week end point (T2) data collection
Secondary Outcomes (3)
Examine PNF-induced changes in sleep (i.e., duration, quality) and insomnia as compared to the HED-Only Control condition.
Baseline (T1) and 8-week end point (T2) data collection
Examine PNF-induced changes in sleep (i.e., duration, quality) and insomnia as compared to the HED-Only Control condition.
Baseline (T1) and 8-week end point (T2) data collection
Examine PNF-induced changes in quality of life as compared to the HED-Only Control condition.
Baseline (T1) and 8-week end point (T2) data collection.
Other Outcomes (4)
Exploratory Aim: Explore acceptability of the PNF intervention
8-week end point (T2) data collection
Exploratory Aim: Explore acceptability of the PNF intervention
8-week end point (T2) data collection
Exploratory Aim: Explore acceptability of the PNF intervention
8-week end point (T2) data collection
- +1 more other outcomes
Study Arms (2)
Prolonged Nightly Fasting and Health Education Videos
EXPERIMENTALParticipants in the Prolonge + HED condition will receive both the Prolonged Nightly Fasting and the Health Education Video interventions.
Health Education Videos Only
ACTIVE COMPARATORParticipants in the Health Education Only condition will participate in only the Health Education Video intervention. Investigators will provide materials about Prolonged Nightly Fasting to these participants at the end of the study.
Interventions
At the start of the intervention (week 1) PNF participants will be asked to engage in fasting (14 hours a night, starting no later than 8pm) six nights a week (for the 8-week study duration). Participants will be asked to track their fasting start/stop times on a tracking sheet provided by study staff. During the nightly fast, participants will be allowed to drink water, coffee or tea (without dairy or sweeteners). Study staff will meet with participants via phone for weekly check-in calls (\~10-15 mins) to collect weekly fasting start/stop dates/times (entered into REDCap); alternately, participants may elect to email or text their fasting start/stop date/times to the study staff.
Provision of HED is a retention strategy and can influence outcomes. Thus, all participants will receive HED. Each week, participants will receive hyperlinks to videos focused on health educational content unrelated to fasting, diet and outcome measures. Participants will be asked to view the videos (\~10-15 min) prior to their weekly check-in calls with the study staff (\~5-10 mins for HED-Only Control group). They will receive each week's videos on a Monday, and receive a reminder to view on Friday. Study staff will follow a scripted HED weekly check-in call to ensure consistency of data collected. Weekly topics are as follows: W1: Internet safety, W2: Sun safety, W3: Home safety, W4: Driving safety, W5: Hydration, W6: Dental health, W7: Working environment, W8: Communication. Data collected on electronic forms during all participant/staff check-in calls will be stored in participant-specific ASU Dropbox files.
Eligibility Criteria
You may qualify if:
- ≥18 years old
- diagnosed with breast cancer (all stages included)
- ≥3 months post neoadjuvant or adjuvant chemotherapy (maintenance or palliative systemic therapy is included)
- score ≤30 or lower on the Patient Reported Outcome Measurement Information System Cognitive Function Short Form 8a (sr-CRCI)
- able to speak/understand English
- have access to a computer and Wi-Fi
- live within the United States
- Identifies as female
- willing and able to fully participate in the study
You may not qualify if:
- type 1 diabetes
- actively enrolled in formal diet/weight loss program
- previous bariatric surgery
- eating disorder history
- night shift work
- pregnant, breast feeding, or trying to get pregnant
- dementia, psychological, psychiatric, or neurological diagnoses
- active brain or central nervous system disease
- prior or current use of memory enhancing medications
- history or current brain radiation
- frequently fasting for 12+ hours every night
- \) history of hypoglycemia 14) depression screening on PHQ9 with a score of 20 or greater across all 9 questions OR anything other than 0 on question 9
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Arizona State Universitylead
- Mayo Cliniccollaborator
Study Sites (1)
Arizona State University
Phoenix, Arizona, 85004, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dorothy Sears, PhD
Arizona State University
- PRINCIPAL INVESTIGATOR
Sarah James, MD, PhD
Mayo Clinic
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- Statistician will also be masked to condition
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Executive Director and Professor
Study Record Dates
First Submitted
March 28, 2025
First Posted
April 22, 2025
Study Start
March 18, 2025
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
May 1, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Protocol and consent state, "De-identified data collected as a part of this study will not be shared with other investigators or industry partners for future research purposes." This is a pilot study and only aggregated data may be shared.